Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques-Eric Gottenberg

Showing results (211-220 of 311) with videos related to

Pageof 32
Sort By:
Modern Rheumatology|April 2, 2022
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 yearsNaoki Ishiguro, Yoshiya Tanaka, Tsukasa Matsubara, et al.
JAMA Dermatology|September 12, 2025
Cutaneous Vasculitis in Primary Sjögren DiseasePaul Breillat, Véronique Le Guern, Thomas d'Humières, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
The Lancet. Rheumatology|January 30, 2024
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measureSuzanne Arends, Liseth de Wolff, Jolien F van Nimwegen, et al.
Joint Bone Spine|May 1, 2022
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesRenaud Felten, Marion Geoffroy, Loïs Bolko, et al.
Joint Bone Spine|July 9, 2010
Tocilizumab: therapy and safety managementThao Pham, Pascal Claudepierre, Arnaud Constantin, et al.
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
Modern Rheumatology|December 4, 2020
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)Tsutomu Takeuchi, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Annals of the Rheumatic Diseases|March 8, 2011
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritisMaya H Buch, Josef S Smolen, Neil Betteridge, et al.
Arthritis Research & Therapy|September 18, 2020
Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trialArsene Mekinian, David Saadoun, Eric Vicaut, et al.
Pageof 32

Showing results (211-220 of 311) with videos related to

Sort By:
Pageof 32
Modern Rheumatology|April 2, 2022
Integrated safety analysis of filgotinib treatment for rheumatoid arthritis in patients from Japan over a median of 1.5 yearsNaoki Ishiguro, Yoshiya Tanaka, Tsukasa Matsubara, et al.
JAMA Dermatology|September 12, 2025
Cutaneous Vasculitis in Primary Sjögren DiseasePaul Breillat, Véronique Le Guern, Thomas d'Humières, et al.
Rheumatology (Oxford, England)|December 19, 2018
Is early-onset primary Sjögren's syndrome a worse prognosis form of the disease?Céline Anquetil, Eric Hachulla, François Machuron, et al.
The Lancet. Rheumatology|January 30, 2024
Composite of Relevant Endpoints for Sjögren's Syndrome (CRESS): development and validation of a novel outcome measureSuzanne Arends, Liseth de Wolff, Jolien F van Nimwegen, et al.
Joint Bone Spine|May 1, 2022
Different anti-SARS-CoV-2 vaccine response under B- and T-cell targeted therapies versus anti-cytokine therapies in patients with inflammatory arthritidesRenaud Felten, Marion Geoffroy, Loïs Bolko, et al.
Joint Bone Spine|July 9, 2010
Tocilizumab: therapy and safety managementThao Pham, Pascal Claudepierre, Arnaud Constantin, et al.
Infectious Diseases and Therapy|July 10, 2021
Refining "Long-COVID" by a Prospective Multimodal Evaluation of Patients with Long-Term Symptoms Attributed to SARS-CoV-2 InfectionMarc Scherlinger, Renaud Felten, Floriane Gallais, et al.
Modern Rheumatology|December 4, 2020
Efficacy and safety of filgotinib in Japanese patients with refractory rheumatoid arthritis: Subgroup analyses of a global phase 3 study (FINCH 2)Tsutomu Takeuchi, Tsukasa Matsubara, Tatsuya Atsumi, et al.
Annals of the Rheumatic Diseases|March 8, 2011
Updated consensus statement on the use of rituximab in patients with rheumatoid arthritisMaya H Buch, Josef S Smolen, Neil Betteridge, et al.
Arthritis Research & Therapy|September 18, 2020
Tocilizumab in treatment-naïve patients with Takayasu arteritis: TOCITAKA French prospective multicenter open-labeled trialArsene Mekinian, David Saadoun, Eric Vicaut, et al.
Pageof 32